Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A Perspective

Number of the records: 1

Title	Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A Perspective
Author	Baka T.
Co-authors	Repova Bednarova Kristina
	Ľupták Ivan
	Šimko Fedor SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV ^ORCID

Source document	Current Pharmaceutical Design. Vol. 28, no. 19 (2022), p. 1581 - 1588
Language	eng - English
Country	NL - Netherlands
Document kind	rozpis článkov z periodík (rbx)
Citations	DELGADO-BETANCOURT, V. - CHINDA, K. - MESIRCA, P. - BARRèRE, C. - COVINHES, A. - GALLOT, L. - VINCENT, A. - BIDAUD, I. - KUMPHUNE, S. - NARGEOT, J. - PIOT, C. - WICKMAN, K. - MANGONI, M.E. - BARRèRE-LEMAIRE, S. Heart rate reduction after genetic ablation of L-type Casubv/sub1.3 channels induces cardioprotection against ischemia-reperfusion injury. In FRONTIERS IN CARDIOVASCULAR MEDICINE. ISSN 2297-055X, AUG 1 2023, vol. 10. Dostupné na: https://doi.org/10.3389/fcvm.2023.1134503.
Category	ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2022
Registered in	WOS
Registered in	SCOPUS
Registered in	CCC
DOI	10.2174/1381612828666220328114236

article

	File name	Access	Size	Downloaded	Type	License
	Ivabradine in the Management of COVID-19-related Cardiovascular Complications.pdf	available	1.9 MB	1	Publisher's version

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	A

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2022	2021	3.310	Q3	0.571	Q2

Number of the records: 1